X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6575) 6575
Publication (551) 551
Book Review (89) 89
Newsletter (39) 39
Newspaper Article (9) 9
Book Chapter (8) 8
Dissertation (7) 7
Conference Proceeding (3) 3
Book / eBook (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5271) 5271
oncology (4689) 4689
paclitaxel (4230) 4230
female (4024) 4024
chemotherapy (3630) 3630
index medicus (3614) 3614
middle aged (2981) 2981
antineoplastic combined chemotherapy protocols - therapeutic use (2767) 2767
aged (2764) 2764
cancer (2496) 2496
carboplatin (2322) 2322
adult (2314) 2314
paclitaxel - administration & dosage (2176) 2176
male (2094) 2094
cisplatin (1860) 1860
treatment outcome (1636) 1636
lung neoplasms - drug therapy (1575) 1575
carboplatin - administration & dosage (1558) 1558
carcinoma, non-small-cell lung - drug therapy (1409) 1409
antineoplastic combined chemotherapy protocols - adverse effects (1225) 1225
care and treatment (1197) 1197
neoplasm staging (1131) 1131
ovarian cancer (1057) 1057
trial (1027) 1027
ovarian neoplasms - drug therapy (997) 997
disease-free survival (990) 990
carcinoma (976) 976
aged, 80 and over (946) 946
lung neoplasms - pathology (925) 925
cisplatin - administration & dosage (919) 919
docetaxel (919) 919
research (904) 904
survival (888) 888
bevacizumab (870) 870
medicine & public health (865) 865
gemcitabine (864) 864
antineoplastic agents - therapeutic use (820) 820
combination (807) 807
pharmacology & pharmacy (802) 802
therapy (802) 802
carcinoma, non-small-cell lung - pathology (762) 762
survival rate (762) 762
phase-iii trial (737) 737
prognosis (729) 729
paclitaxel - adverse effects (728) 728
drug administration schedule (703) 703
hematology, oncology and palliative medicine (702) 702
lung cancer, non-small cell (694) 694
metastasis (688) 688
breast cancer (684) 684
lung cancer (683) 683
drug therapy (676) 676
survival analysis (672) 672
clinical trials (664) 664
phase-ii trial (652) 652
analysis (644) 644
antineoplastic agents (643) 643
deoxycytidine - analogs & derivatives (642) 642
antineoplastic combined chemotherapy protocols - administration & dosage (619) 619
obstetrics & gynecology (615) 615
retrospective studies (614) 614
paclitaxel - therapeutic use (613) 613
antimitotic agents (601) 601
cancer therapies (569) 569
breast neoplasms - drug therapy (566) 566
tumors (560) 560
non-small cell lung cancer (553) 553
deoxycytidine - administration & dosage (539) 539
health aspects (521) 521
ovarian neoplasms - pathology (509) 509
carboplatin - adverse effects (507) 507
combined modality therapy (504) 504
lung neoplasms - mortality (500) 500
respiratory system (493) 493
phase-ii (489) 489
radiotherapy (466) 466
cyclophosphamide (463) 463
gynecologic-oncology-group (462) 462
cancer research (461) 461
carcinoma, non-small-cell lung - mortality (459) 459
surgery (451) 451
cell lung-cancer (449) 449
randomized-trial (449) 449
patients (447) 447
open-label (436) 436
animals (435) 435
antineoplastic agents - administration & dosage (418) 418
oncology, experimental (410) 410
taxoids - administration & dosage (404) 404
toxicity (404) 404
doxorubicin (392) 392
neoplasm recurrence, local - drug therapy (391) 391
pharmacology/toxicology (386) 386
dose-response relationship, drug (380) 380
1st-line treatment (375) 375
follow-up studies (367) 367
chemotherapy, adjuvant (364) 364
clinical trials as topic (360) 360
phase-iii (349) 349
vinorelbine (348) 348
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6555) 6555
Japanese (42) 42
Chinese (25) 25
French (20) 20
German (13) 13
Spanish (5) 5
Korean (2) 2
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 34, pp. 4349 - 4357
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 10/2006, Volume 24, Issue 29, pp. 4699 - 4707
Purpose Most patients with advanced ovarian cancer develop recurrent disease. For those patients who recur at least 6 months after initial therapy, paclitaxel... 
PHASE-III TRIAL | ONCOLOGY-GROUP | CISPLATIN | ONCOLOGY | END-POINT | TOXICITY CRITERIA | CLINICAL-TRIALS | DISEASE | QUALITY-OF-LIFE | CARCINOMA | PACLITAXEL
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 396 - 405
Journal Article
The Oncologist, ISSN 1083-7159, 06/2007, Volume 12, Issue 6, pp. 713 - 718
Journal Article
Annals of Oncology, ISSN 0923-7534, 08/2018, Volume 29, Issue 8, pp. 1763 - 1770
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 101 - 114
Journal Article
Journal Article